Peptide inhibitor of complement C1 (PIC1), a novel suppressor of classical pathway activation: mechanistic studies and clinical potential
The classical pathway of complement plays multiple physiological roles including modulating immunological effectors initiated by adaptive immune responses as well as an essential homeostatic role in the clearance of damaged self-antigens. However, dysregulated classical pathway activation is associa...
Main Authors: | Julia A Sharp, Pamela H. Whitley, Kenji M. Cunnion, Neel Kumar Krishna |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00406/full |
Similar Items
-
Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1
by: Pamela S. Hair, et al.
Published: (2018-03-01) -
Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1).
by: Pamela S Hair, et al.
Published: (2017-01-01) -
Inhibition of complement activation, myeloperoxidase, NET formation and oxidant activity by PIC1 peptide variants.
by: Pamela S Hair, et al.
Published: (2019-01-01) -
The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides, Additional Mechanisms of Action, and In Vivo and Ex Vivo Efficacy
by: Neel K. Krishna, et al.
Published: (2022-02-01) -
Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.
by: Parvathi Kumar, et al.
Published: (2021-01-01)